Showing 2990 results
-
Clinical Trials /
-
Clinical Trials /
-
Clinical Trials /
-
Clinical Trials /
-
Clinical Trials /
-
Statement /
-
Story /Novartis chemists receive “Heroes of Chemistry” honor from the American Chemical Society for work on CML drug discovery.
-
Story /Novartis has announced new long-term Social Impact & Sustainability (SI&S) targets and goals, reinforcing our commitment to go beyond breakthroughs to maximize the impact of our medicines to support inclusive, resilient healthcare systems worldwide.
-
Press release /If approved, Cosentyx (secukinumab) will be first IL-17A inhibitor licensed in Europe for adults with polymyalgia rheumatica (PMR), providing new treatment option after steroids¹Recommendation based…